Prevention of stroke in patients with high-risk atrial fibrillation

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Atrial fibrillation (AF) causes nearly 10% of all ischemic strokes. Long-term oral anticoagulation with warfarin currently is the best treatment for preventing stroke in patients with AF and other stroke risk factors. However, many eligible patients do not receive warfarin, and some patients with AF are unsuitable for this treatment. Recent clinical trials have tested alternatives to long-term warfarin, and some new treatment options have emerged. Nonpharmacologic approaches to stroke prevention in atrial fibrillation also are under development. In addition, new diagnostic modalities may detect paroxysmal AF with more sensitivity, potentially expanding the population to be treated and the potential impact of stroke preventive strategies on the population. This review provides a practical guide to current treatment and diagnostic options.

Original languageEnglish (US)
Pages (from-to)34-39
Number of pages6
JournalCurrent neurology and neuroscience reports
Issue number1
StatePublished - Jan 2010


  • Anticoagulation
  • Atrial fibrillation
  • Cardioembolic stroke
  • Stroke prevention

ASJC Scopus subject areas

  • Clinical Neurology
  • General Neuroscience


Dive into the research topics of 'Prevention of stroke in patients with high-risk atrial fibrillation'. Together they form a unique fingerprint.

Cite this